Persistent Janus Kinase-Signaling in Chronic Lymphocytic Leukemia Patients on Ibrutinib: Results of a Phase I Trial

Cancer Medicine - United Kingdom
doi 10.1002/cam4.2042
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy